Analysis of 237 cases of thyroid related adverse reactions induced by lithium carbonate

Corresponding author: liu yong li, liuyongli2008@126.com

DOI: 10.12201/bmr.202503.00087

•  

  Abstract: Abstract Objective Investigate the regularity and characteristics of lithium carbonate-induced thyroid adverse reactions ( ADR ), to provide reference for clinical rational drug use. Methods The case reports of thyroid ADR caused by lithium carbonate in the National Adverse Drug Reaction Monitoring System were retrieved, and the gender and age of patients, medication reasons, combined medication, dosage and clinical manifestations of thyroid ADR were retrospectively analyzed. Results A total of 237 cases of thyroid ADRs caused by lithium carbonate were reported, the ratio of male to female was 1:1.7, the frequency was higher in the age group of 20 to 29 years, and the proportion of drug use within the range of instruction dosage was 97.8%. According to the statistics of drugs used in combination, the most drugs were drugs for mental disorders, and the time of ADR occurrence was mostly 10 to 30 days after taking the drug. The main clinical manifestations of thyroid ADR were hypothyroidism, goiter and hyperthyroidism. Conclusion Lithium carbonate-induced thyroid ADR mostly occurred at the therapeutic dose, which was related to the patient s gender, age, combined medication and other factors. Clinicians and pharmacists should master the rules and characteristics of thyroid caused by lithium carbonate, timely detect and treat ADR, to provide guarantee for the safety of patients medication.

  Key words: Lithium carbonate; thyroid hormone; hypothyroidism; goiter enlargement; hyperthyroidism; adverse reactions; safety

  Submit time: 31 March 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Wang Huan, Ma Ying, Tian Jingnan, Lu Yi. Progress in the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Hypothyroidism from the Perspectives of Traditional Chinese and Western Medicine. 2025. doi: 10.12201/bmr.202505.00004

  Zhu Xiaojing. . 2024. doi: 10.12201/bmr.202412.00015

  JIA Bei, DAI Yuanyuan. Sintilimab-induced Diabetes Ketoacidosis with multiple organ immune related adverse reactions:A Clinical Case. 2024. doi: 10.12201/bmr.202411.00022

  zhaoxuelian. Mendelian randomization study on the relationship between thyroid dysfunction and insomnia. 2025. doi: 10.12201/bmr.202504.00066

  QIAN Yun. Adverse events associated with immune checkpoint inhibitors: clinical manifestations and mechanisms. 2025. doi: 10.12201/bmr.202502.00010

  YU Feng, ZOU Xiao-jie, XU Zhen. The relationship between hyperactivity behavior in children with attention deficit hyperactivity disorder and serum levels of thyroid-stimulating hormone. 2024. doi: 10.12201/bmr.202411.00024

  Bai Xiaolin, Zhang ZeQun. Syndrome Differentiation and Treatment of Thyroid Nodules Based on the Theory of Smooth Flow of Primordial True Qi in Five Zang-Organs. 2025. doi: 10.12201/bmr.202506.00063

  CHEN Manman, TENG Yuxin, ZENG Botao. Study on self-injurious and suicidal behavior, non-enzymatic antioxidants and thyroid hormones in adolescents with depressive disorder. 2024. doi: 10.12201/bmr.202412.00022

  SHANG Hongqing. Diagnosis and Treatment of a Thyroid Foreign Body: a Case Report and Literature Review. 2025. doi: 10.12201/bmr.202509.00009

  liujing, panyaweng, rengzheng. Progress in robotic thyroidectomy in the treatment of thyroid cancer. 2024. doi: 10.12201/bmr.202411.00030

• ID	Submit time	Number	Download
  1	2025-03-03	10.12201/bmr.202503.00087V1	Download

• Public  Anonymous  To author only Submit Comments